# GABAPENTIN

NDC: 69097-815
Generic name: GABAPENTIN
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20160629

FDA application: ANDA090705

## Active ingredients

- GABAPENTIN: 400 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-815"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-815
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e4eca9c-6a2c-4ede-a252-1a27094bf594